The influence of lithium on hippocampal volume in elderly bipolar patients: a study using voxel-based morphometry
Carregando...
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
NATURE PUBLISHING GROUP
Citação
TRANSLATIONAL PSYCHIATRY, v.6, article ID e846, 7p, 2016
Resumo
Recent studies have demonstrated that lithium (Li) exerts neuronal protective and regenerative effects both in vitro and in vivo. However, the effects of long-term Li treatment in the brain areas associated with memory impairment of elderly bipolar patients are still unknown. The aim of this study was to compare the hippocampal volumes of elderly bipolar patients using Li, elderly bipolar patients not using Li and healthy controls. Sociodemographic, clinical and magnetic resonance imaging data from 30 elderly euthymic bipolar patients who had been using Li for an average of >61 months; 27 elderly euthymic bipolar patients not taking Li for an average of 45 months; and 22 elderly healthy controls were analyzed. Volumetric differences in the hippocampus between groups were investigated with voxel-based morphometry (VBM) based on the Statistical Parametric Mapping technique. No statistical differences in sociodemographic and clinical characteristics and course of bipolar disorder between the two bipolar groups were observed. Using small volume correction in the VBM analysis (analysis of variance (ANOVA)), one voxel cluster of statistical significance was detected in the left hippocampus (P<0.05 corrected for multiple comparisons, extent threshold >10 voxels). Post hoc unpaired t-tests revealed increased left hippocampal volume in the Li-treated group compared with the non-Li-treated group, and decreased left hippocampal volume in the non-Li group relative to controls. Additional exploratory two-group comparisons indicated trends toward reduced right-hippocampal volumes in the non-Li-treated group relative to both the Li-treated group and controls. The findings suggested that the use of Li may influence the volume of the hippocampus, possibly due to its neuroprotective effects.
Palavras-chave
Referências
- Angelucci F, 2003, INT J NEUROPSYCHOPH, V6, P225, DOI 10.1017/S1461145703003468
- Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582
- Bearden CE, 2007, BIOL PSYCHIAT, V62, P7, DOI 10.1016/j.biopsych.2006.10.027
- Berk M, 2009, INT J NEUROPSYCHOPH, V12, P441, DOI 10.1017/S1461145708009498
- Beyer JL, 2004, AM J GERIAT PSYCHIAT, V12, P613, DOI 10.1176/appi.ajgp.12.6.613
- Brambilla P, 2009, CURR PHARM DESIGN, V15, P2632
- Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756
- Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005
- Cade JFJ, 2000, B WORLD HEALTH ORGAN, V78, P518
- Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598
- Chen G, 2000, J NEUROCHEM, V75, P1729, DOI 10.1046/j.1471-4159.2000.0751729.x
- Chuang De-Maw, 2004, Critical Reviews in Neurobiology, V16, P83, DOI 10.1615/CritRevNeurobiol.v16.i12.90
- Chuang DM, 2005, ANN NY ACAD SCI, V1053, P195, DOI 10.1196/annals.1344.018
- Diniz BS, 2013, NEUROPSYCH DIS TREAT, V9, P493, DOI 10.2147/NDT.S33086
- Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305
- Foland LC, 2008, NEUROREPORT, V19, P221, DOI 10.1097/WNR.0b013e3282f48108
- Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074
- Fritschy JM, 2012, CELL MOL LIFE SCI, V69, P2485, DOI 10.1007/s00018-012-0926-4
- Germana C, 2010, ACTA PSYCHIAT SCAND, V122, P481, DOI 10.1111/j.1600-0447.2010.01582.x
- Gildengers AG, 2015, BIPOLAR DISORD, V17, P248, DOI 10.1111/bdi.12260
- Gispert JD, 2003, NEUROIMAGE, V19, P601, DOI 10.1016/S1053-8119(03)00072-7
- Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786
- GOODWIN FK, 1969, ARCH GEN PSYCHIAT, V21, P486
- Hajek T, 2012, J PSYCHIATR NEUROSCI, V37, P333, DOI 10.1503/jpn.110143
- Hallahan B, 2011, BIOL PSYCHIAT, V69, P326, DOI 10.1016/j.biopsych.2010.08.029
- Hashimoto R, 2003, NEUROSCIENCE, V117, P55, DOI 10.1016/S0306-4522(02)00577-8
- Hennion JP, 2002, BIPOLAR DISORD, V4, P201, DOI 10.1034/j.1399-5618.2002.01162.x
- Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326
- JORM AF, 1989, PSYCHOL MED, V19, P1015
- Kauer-Sant'Anna M, 2009, INT J NEUROPSYCHOPH, V12, P447, DOI 10.1017/S1461145708009310
- Keener Matthew T, 2007, Curr Psychiatry Rep, V9, P512, DOI 10.1007/s11920-007-0070-2
- Kubicki M, 2002, NEUROIMAGE, V17, P1711, DOI 10.1006/nimg.2002.1296
- Kupfer DJ, 2005, JAMA-J AM MED ASSOC, V293, P2528, DOI 10.1001/jama.293.20.2528
- Lueke K, 2014, J NEURAL TRANSM, V121, P211, DOI 10.1007/s00702-013-1087-9
- Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597
- MAZZIOTTA JC, 1994, WESTERN J MED, V161, P273
- MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764
- Mitchell PB, 2000, B WORLD HEALTH ORGAN, V784, P515
- MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382
- Moore GJ, 2000, LANCET, V356, P1241, DOI 10.1016/S0140-6736(00)02793-8
- Moorhead TWJ, 2007, BIOL PSYCHIAT, V62, P894, DOI 10.1016/j.biopsych.2007.03.005
- Nonaka S, 1998, P NATL ACAD SCI USA, V95, P2642, DOI 10.1073/pnas.95.5.2642
- Pantelis C, 2003, AUST NZ J PSYCHIAT, V37, P399, DOI 10.1046/j.1440-1614.2003.01193.x
- Perroco TR, 2009, INT PSYCHOGERIATR, V21, P531, DOI 10.1017/S1041610209008849
- Plotnikov EY, 2014, BIOCHEMISTRY-MOSCOW+, V79, P740, DOI 10.1134/S0006297914080021
- Robinson LJ, 2006, BIPOLAR DISORD, V8, P103, DOI 10.1111/j.1399-5618.2006.00277.x
- ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698
- Savitz J, 2010, NEUROIMAGE, V49, P2966, DOI 10.1016/j.neuroimage.2009.11.025
- SCHOU M, 1954, J NEUROL NEUROSUR PS, V17, P250, DOI 10.1136/jnnp.17.4.250
- Soeiro-de-Souza MG, 2013, INT J NEUROPSYCHOPH, V16, P1505, DOI 10.1017/S1461145713000047
- Son H, 2003, J NEUROCHEM, V85, P872, DOI 10.1046/j.1471-4159.2003.01725.x
- Swann AC, 2000, ACTA PSYCHIAT SCAND, V101, P444, DOI 10.1034/j.1600-0447.2000.101006444.x
- Talairach J., 1988, COPLANAR STEREOTAXIC
- Tyagarajan SK, 2014, NAT REV NEUROSCI, V15, P141, DOI 10.1038/nrn3670
- Uchida RR, 2008, PSYCHIAT RES-NEUROIM, V163, P21, DOI 10.1016/j.pscychresns.2007.04.015
- Usher J, 2010, ACTA PSYCHIAT SCAND, V121, P119, DOI 10.1111/j.1600-0447.2009.01428.x
- World Health Organization (WHO), 1993, ICD 10 CLASS MENT BE
- Wood GE, 2004, P NATL ACAD SCI USA, V101, P3973, DOI 10.1073/pnas.0400208101
- YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429
- Yucel K, 2008, NEUROPSYCHOPHARMACOL, V33, P361, DOI 10.1038/sj.npp.1301405
- Yucel K, 2007, PSYCHOPHARMACOLOGY, V195, P357, DOI 10.1007/s00213-007-0906-9
- Zanni G, 2015, ONCOTARGET, V6, P37083, DOI 10.18632/oncotarget.5191